Ephedrine, Raw Materials To Make Drug Seized In Akola District; Five Held

AkolaPolice in Maharashtra ’s Akola district have seized Rs 2.38 crore worth of ephedrine and raw materials to make the drug from a disused factory and arrested five persons in connection with it, an official said on Thursday.

Ephedrine is a central nervous stimulant and is often misused as a recreational drug.

Acting on inputs, the crime branch recently raided an unused ginning factory, where cotton fibres are separated from cotton seeds, on Mahagaon Road and confiscated 5.5 kg of ephedrine and raw materials worth Rs 2.38 crore.

Five persons have been arrested for their alleged involvement in the drug business, an official said.

Police said the factory had started producing the drug after October 15 and was still to ship out its first consignment. One of the accused, Adil Mohammad Shameem Ansari (36) was named in some police cases in Mumbai and Hyderabad.

Superintendent of Police Bachchan Singh said they are trying to ascertain where the drug was intended to be delivered.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre